Christopher Gibson
Director at Recursion Pharmaceuticals; Director at Pacific Biosciences of California. Based in Salt Lake City, Utah.
- Rank
- 5914th of 14,644
- Companies held
- 2
- Largest holding
- RXRX, 98.8% of total
- Latest SEC filing
- Jun 5, 2026
What the $16.7M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Recursion Pharmaceuticals RXRX Class B Common Stock | Directly | 4,263,334 | $2.72 | $11.6M | 69.4% | Form 4, Jun 5, 2026 |
| Recursion Pharmaceuticals RXRX Class A Common Stock | Directly | 883,735 | $2.72 | $2.4M | 14.4% | Form 4, Jun 5, 2026 |
| Recursion Pharmaceuticals RXRX Class B Common Stock | Through LAHWRAN-4 LLC | 388,000 | $2.72 | $1.1M | 6.3% | Form 4, Jun 5, 2026 |
| Recursion Pharmaceuticals RXRX Class B Common Stock | Through LAHWRAN-3 LLC | 386,000 | $2.72 | $1.0M | 6.3% | Form 4, Jun 5, 2026 |
| Recursion Pharmaceuticals RXRX Class A Common Stock | Through Gibson Family Trust | 100,000 | $2.72 | $272K | 1.6% | Form 4, Aug 11, 2025 |
| Pacific Biosciences of California PACB Common Stock | Directly | 111,386 | $1.76 | $196K | 1.2% | Form 4, Apr 8, 2026 |
| Recursion Pharmaceuticals RXRX Class B Common Stock | Through Gibson Family Trust | 50,000 | $2.72 | $136K | 0.8% | Form 4, Jun 5, 2026 |
Share counts are the amounts Christopher Gibson reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jun 5, 2026 | Sold | RXRX | 40,000 | $3.62 | $145K | View |
| May 22, 2026 | Sold | RXRX | 40,000 | $3.08 | $123K | View |
| May 7, 2026 | Sold | RXRX | 40,000 | $3.37 | $135K | View |
| Apr 22, 2026 | Sold | RXRX | 40,000 | $3.61 | $144K | View |
| Apr 7, 2026 | Sold | RXRX | 40,000 | $3.10 | $124K | View |
| Mar 23, 2026 | Sold | RXRX | 40,000 | $3.25 | $130K | View |
| Feb 19, 2026 | Sold | RXRX | 40,000 | $3.46 | $138K | View |
| Feb 4, 2026 | Sold | RXRX | 40,000 | $4.12 | $165K | View |
| Jan 20, 2026 | Sold | RXRX | 40,000 | $4.47 | $179K | View |
| Jan 5, 2026 | Sold | RXRX | 40,000 | $4.25 | $170K | View |
| Dec 19, 2025 | Sold | RXRX | 40,000 | $4.50 | $180K | View |
| Dec 4, 2025 | Sold | RXRX | 40,000 | $4.63 | $185K | View |
| Nov 19, 2025 | Sold | RXRX | 40,000 | $4.16 | $166K | View |
| Nov 4, 2025 | Sold | RXRX | 40,000 | $5.21 | $208K | View |
| Oct 23, 2025 | Sold | RXRX | 100,000 | $5.70 | $570K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 5911 | Jeffrey M. Farber Executive Vice President, The Hanover Insurance Group. Worcester, MA | $16.7M |
| 5912 | Levien Meredith A. Kopit PRESIDENT & CEO, The New York Times. San Francisco, CA | $16.7M |
| 5913 | Jennifer K. Mann Executive Vice President, The Coca-Cola. Atlanta, GA | $16.7M |
| 5914 | Christopher Gibson Director, Recursion Pharmaceuticals. Salt Lake City, UT | $16.7M |
| 5915 | Mark Vergnano Director, The Chemours. Milwaukee, WI | $16.7M |
| 5916 | Frank T. Connor Executive Vice President & CFO, Textron. New York, NY | $16.7M |
| 5917 | Ronald Blake Chatelain See Remarks, Red River Bancshares. Alexandria, LA | $16.7M |
Other Recursion Pharmaceuticals insiders
All RXRX insiders- Blake Borgeson$16.5MDirector. #5982 overall
- Dean Y. Li$9.4MDirector. #4831 overall
- Najat Khan$5.4MCEO and President. #13706 overall
- Michael Secora$4.0MChief Financial Officer. #10347 overall
- Fred Hassan$426KDirector. #9297 overall
Questions
How much stock does Christopher Gibson own?
Christopher Gibson holds $16,709,347 in listed stock based on SEC filings and current prices, mostly Recursion Pharmaceuticals (RXRX). That ranks 5914th on the Stock Rich List.
Is this Christopher Gibson's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Christopher Gibson last buy or sell stock?
The most recent open-market trade on file is a sale of 40,000 RXRX shares on Jun 5, 2026 at $3.62.